Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ginsenoside Rg3 plus First-line Chemotherapy in Advanced Gastric Cancer
NCT01757366Phase 2Unknown
- Sponsor
- Hebei Cancer Hospital
- Start
- Dec 2012
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ginsenoside Rg3 in gastric cancer (GC), sponsored by Hebei Cancer Hospital. Status: unknown.
02
Drugs
ginsenoside Rg3
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT01757366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01757366.